Neoimmun (Ciclosporin)

Ciclosporin, the active ingredient in Neoimmun, is a calcineurin inhibitor presented as an oral dosage form for oral use. It suppresses immune activity and is employed in organ transplantation, rheumatoid arthritis and psoriasis management. GNH USA supplies Neoimmun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.

Neoimmun, a calcineurin inhibitor, is used in conditions where immune modulation is required.

Organ transplantation: prevents graft rejection by inhibiting T‑cell activation. Rheumatoid arthritis: reduces joint inflammation and disease progression. Psoriasis: controls severe plaque psoriasis by dampening immune‑driven skin cell proliferation.

Ciclosporin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Headache: mild to moderate intensity. - Hypertension: elevated blood pressure requiring monitoring. - Hyperlipidaemia: increased cholesterol and triglycerides. - Gingival hyperplasia: overgrowth of gum tissue. - Tremor: fine shaking of hands. - Hirsutism: excessive hair growth.

Serious or Rare Side Effects: - Nephrotoxicity: impaired kidney function. - Severe infections: opportunistic bacterial, viral or fungal infections. - Hepatotoxicity: liver enzyme elevation or injury. - Lymphoma: increased risk of certain cancers. - Anaphylaxis: rare severe allergic reaction. - Seizures: neurological events in predisposed patients.

Before initiating Neoimmun, clinicians should assess baseline health and monitor ongoing parameters. - Renal function: check serum creatinine and glomerular filtration rate regularly. - Blood pressure: monitor and manage hypertension throughout therapy. - Lipid profile: assess cholesterol and triglycerides periodically. - Infection risk: avoid live vaccines and screen for latent infections. - Hepatic impairment: adjust dose in patients with liver dysfunction. - Store at ambient temperature: keep below 25 °C in original packaging, protect from moisture and direct sunlight.

Ciclosporin interacts with several drug classes; awareness of interaction severity guides clinical decisions.

Major Interactions (Avoid): - Ketoconazole: potent CYP3A4 inhibition markedly raises ciclosporin levels. - Erythromycin: macrolide antibiotic that can increase drug exposure. - Azole antifungals (e.g., fluconazole): elevate plasma concentrations. - Grapefruit juice: inhibits metabolism leading to toxicity. - Ritonavir: strong CYP3A4 inhibitor causing dangerous accumulation.

Moderate Interactions (Monitor Closely): - Calcium channel blockers (e.g., diltiazem): may increase levels, require dose adjustment. - Statins (e.g., simvastatin): risk of myopathy, monitor muscle symptoms. - NSAIDs: additive nephrotoxic potential, watch renal function. - Diuretics: may enhance hypertension, check blood pressure. - Rifampicin: enzyme inducer that can lower ciclosporin concentrations.